Pharmaceuticals, Biotechnology and Life Sciences
Abzena has issued a statement in which it notes that during the conference call to accompany Gilead Sciences Inc.’s (‘Gilead’) announcement of third quarter
Pfizer announced today the discontinuation of the global clinical development program for bococizumab…
Novartis gets FDA Priority Review for first-line treatment of HR+/HER2-advanced breast cancer
India’s Strides Shasun Limited has received approval from the USFDA for Abacavir Tablets
New way to to perform transcatheter aortic valve replacemen successful in high-risk patients
Mylan NV’s price hikes on EpiPens have added millions to U.S. Department of Defense spending…
HeartWare is recalling the HVAD controller due to a loose power connector which may cause …
Sanofi and Regeneron Pharmaceuticals have announced the FDA issued a Complete Response Letter (CRL) regarding…
Sanofi will accept any blame attributed to it by a court over the harmful effects…
AstraZeneca’s high hopes for cancer immunotherapy were dented on Thursday as the recruitment